© 2020 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Patient Engagement
Rare Diseases: Building Long Term Relationships
October 15, 2020
Therapeutic companies that work with rare diseases must take early steps to build relationships with patients, caregivers, and HCPs.
Assets in Anxious Times: Patient Hubs Demonstrate Value During COVID-19
October 14, 2020
How ramped-up support and educational services have helped bridge the chasms and ease fears along the patient care continuum.
Critical Connection: Patient Services and Product Launch
October 14, 2020
A look at best-practice approaches to aligning the strategy and design of hub service models with preparations for market entry of a new therapy.
Designing Patient Services Programs
August 28, 2020
Launching a product soon? Here’s how to think about strategy and design for your patient services program.
How Copay Management by Payers Is Evolving
August 18, 2020
A look into the complex battle between pharmaceutical manufacturers and payers for balance between medication access and budget management.
How Oncologists are Coping with COVID-19
July 09, 2020
Report highlights how oncology practices are becoming more virtual-oriented in light of the global pandemic.
COVID & Chronic Disease: Meeting the Needs of Vulnerable Patients
June 01, 2020
Pharma companies are in a unique position to support and educate at-risk populations through patient services hubs.
Patients' Role in Healthcare Decisions Will Transform Industry’s Model of Care
February 04, 2020
David Logue sees the industry adapting to address medical needs and deliver treatments to patients in ways that afford greater personal empowerment.
Engaging with Emotions: Patients as Partners
February 03, 2020
Involving patients more meaningfully in the industry's activities means getting more serious about their emotional wellbeing.